COO of Genomic Health Inc. (GHDX, Financial) G Bradley Cole sells 5,000 shares of GHDX on 01/06/2011 at an average price of $22.13 a share.
Genomic Health Inc. has a market cap of $633.9 million; its shares were traded at around $21.97 with a P/E ratio of 313.8 and P/S ratio of 4.2.
GHDX is in the portfolios of Chuck Royce of Royce& Associates, Jim Simons of Renaissance Technologies LLC.
Genomic Health Inc. has a market cap of $633.9 million; its shares were traded at around $21.97 with a P/E ratio of 313.8 and P/S ratio of 4.2.
GHDX is in the portfolios of Chuck Royce of Royce& Associates, Jim Simons of Renaissance Technologies LLC.
CEO Recent Trades:
- Sell: President and CEO Kimberly J Popovits sold 8,000 shares of GHDX stock on 12/16/2010 at the average price of 22.71. Kimberly J Popovits owns at least 310,624 shares after this. The price of the stock has decreased by 3.26% since.
- Sell: President and CEO Kimberly J Popovits sold 8,000 shares of GHDX stock on 11/16/2010 at the average price of 17.5. Kimberly J Popovits owns at least 310,624 shares after this. The price of the stock has increased by 25.54% since.
- Sell: President and CEO Kimberly J Popovits sold 7,734 shares of GHDX stock on 09/15/2010 at the average price of 15.1. Kimberly J Popovits owns at least 310,624 shares after this. The price of the stock has increased by 45.5% since.
- Sell: President and CEO Kimberly J Popovits sold 8,000 shares of GHDX stock on 08/17/2010 at the average price of 15.07. Kimberly J Popovits owns at least 288,116 shares after this. The price of the stock has increased by 45.79% since.
CFO Recent Trades:
- Sell: COO & CFO G Bradley Cole sold 2,500 shares of GHDX stock on 12/13/2010 at the average price of 22.64. G Bradley Cole owns at least 1,000 shares after this. The price of the stock has decreased by 2.96% since.
- Sell: COO & CFO G Bradley Cole sold 2,500 shares of GHDX stock on 11/11/2010 at the average price of 18.04. G Bradley Cole owns at least 1,000 shares after this. The price of the stock has increased by 21.78% since.
- Sell: COO & CFO G Bradley Cole sold 2,500 shares of GHDX stock on 09/13/2010 at the average price of 15.01. G Bradley Cole owns at least 1,000 shares after this. The price of the stock has increased by 46.37% since.
- Sell: COO & CFO G Bradley Cole sold 2,500 shares of GHDX stock on 08/12/2010 at the average price of 15. G Bradley Cole owns at least 1,000 shares after this. The price of the stock has increased by 46.47% since.
Directors and Officers Recent Trades:
- Buy: Director, 10% Owner Brothers Life Sciences C Baker bought 5,261 shares of GHDX stock on 09/09/2010 at the average price of 14.81. Brothers Life Sciences C Baker owns at least 4,934,990 shares after this. The price of the stock has increased by 48.35% since.
- Buy: Director, 10% Owner Capital (gp), Llc 14159 bought 145 shares of GHDX stock on 09/09/2010 at the average price of 14.81. Capital (gp), Llc 14159 owns at least 134,196 shares after this. The price of the stock has increased by 48.35% since.
- Buy: Director, 10% Owner Brothers Life Sciences C Baker bought 65,466 shares of GHDX stock on 09/02/2010 at the average price of 14.46. Brothers Life Sciences C Baker owns at least 4,929,729 shares after this. The price of the stock has increased by 51.94% since.
- Buy: Director, 10% Owner Capital (gp), Llc 14159 bought 1,807 shares of GHDX stock on 09/02/2010 at the average price of 14.46. Capital (gp), Llc 14159 owns at least 134,051 shares after this. The price of the stock has increased by 51.94% since.
- Buy: Director, 10% Owner Brothers Life Sciences C Baker bought 123,711 shares of GHDX stock on 08/30/2010 at the average price of 14.37. Brothers Life Sciences C Baker owns at least 4,864,263 shares after this. The price of the stock has increased by 52.89% since.
